Cargando…

Comparison of clinical, para-clinical and laboratory findings in survived and deceased patients with COVID-19: diagnostic role of inflammatory indications in determining the severity of illness

BACKGROUND: Since December 2019, when a cluster of pneumonia cases due to SARS-CoV-2 initially emerged in Wuhan city and then rapidly spread throughout the world, the necessity for data concerning the clinical and para-clinical features of Iranian patients with COVID-19 was highlighted. Therefore, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Rokni, Mohsen, Ahmadikia, Kazem, Asghari, Somaye, Mashaei, Shahabodin, Hassanali, Fahimeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680983/
https://www.ncbi.nlm.nih.gov/pubmed/33225909
http://dx.doi.org/10.1186/s12879-020-05540-3
_version_ 1783612545958936576
author Rokni, Mohsen
Ahmadikia, Kazem
Asghari, Somaye
Mashaei, Shahabodin
Hassanali, Fahimeh
author_facet Rokni, Mohsen
Ahmadikia, Kazem
Asghari, Somaye
Mashaei, Shahabodin
Hassanali, Fahimeh
author_sort Rokni, Mohsen
collection PubMed
description BACKGROUND: Since December 2019, when a cluster of pneumonia cases due to SARS-CoV-2 initially emerged in Wuhan city and then rapidly spread throughout the world, the necessity for data concerning the clinical and para-clinical features of Iranian patients with COVID-19 was highlighted. Therefore, we aimed to compare the clinical, para-clinical and laboratory evidences of deceased patients with survival group. METHODS: We extracted data regarding 233 patients with laboratory-confirmed COVID-19 from Buali Hospital in Iran; clinical/para-clinical and inflammatory indexes data were collected and analyzed. The data of laboratory examinations and chest CT findings were compared between deceased and survived patients. RESULTS: The mean age of the patients was 49.8 years and 64% of our patients were male. The acute respiratory distress syndrome occurred in 64 patients, 52 who were admitted to the ICU, which all of them underwent invasive mechanical ventilation, and 28 who died. Lymphopenia (79%), neutrophilia (79%), and thrombocytopenia (21%) were the most frequently observed laboratory findings of the deceased group on admission. Most patients (68%) had a high systematic immune-inflammation (SII) index of > 500 and increased C-reactive protein level (88%). Levels of inflammatory indexes such as neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR) and SII were documented to be significantly elevated in the deceased group when compared with the patients who survived (P < 0.0001, P < 0.001, P < 0.0001, respectively). The most commonly presented symptoms were fever (70%) and cough (63%) on admission. Headache was uncommon (11%). Ground-glass opacity with consolidation (mixed) was the most common radiologic finding on chest CT (51%). No radiographic or CT abnormality was found in 15 of 204 patients (7%). CONCLUSION: Small fraction of patients with COVID-19 may present without fever and abnormal radiologic findings. Elevated NLR, PLR and SII can be considered as prognostic and risk stratifying factor of severe form of disease. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-020-05540-3.
format Online
Article
Text
id pubmed-7680983
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-76809832020-11-23 Comparison of clinical, para-clinical and laboratory findings in survived and deceased patients with COVID-19: diagnostic role of inflammatory indications in determining the severity of illness Rokni, Mohsen Ahmadikia, Kazem Asghari, Somaye Mashaei, Shahabodin Hassanali, Fahimeh BMC Infect Dis Research Article BACKGROUND: Since December 2019, when a cluster of pneumonia cases due to SARS-CoV-2 initially emerged in Wuhan city and then rapidly spread throughout the world, the necessity for data concerning the clinical and para-clinical features of Iranian patients with COVID-19 was highlighted. Therefore, we aimed to compare the clinical, para-clinical and laboratory evidences of deceased patients with survival group. METHODS: We extracted data regarding 233 patients with laboratory-confirmed COVID-19 from Buali Hospital in Iran; clinical/para-clinical and inflammatory indexes data were collected and analyzed. The data of laboratory examinations and chest CT findings were compared between deceased and survived patients. RESULTS: The mean age of the patients was 49.8 years and 64% of our patients were male. The acute respiratory distress syndrome occurred in 64 patients, 52 who were admitted to the ICU, which all of them underwent invasive mechanical ventilation, and 28 who died. Lymphopenia (79%), neutrophilia (79%), and thrombocytopenia (21%) were the most frequently observed laboratory findings of the deceased group on admission. Most patients (68%) had a high systematic immune-inflammation (SII) index of > 500 and increased C-reactive protein level (88%). Levels of inflammatory indexes such as neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR) and SII were documented to be significantly elevated in the deceased group when compared with the patients who survived (P < 0.0001, P < 0.001, P < 0.0001, respectively). The most commonly presented symptoms were fever (70%) and cough (63%) on admission. Headache was uncommon (11%). Ground-glass opacity with consolidation (mixed) was the most common radiologic finding on chest CT (51%). No radiographic or CT abnormality was found in 15 of 204 patients (7%). CONCLUSION: Small fraction of patients with COVID-19 may present without fever and abnormal radiologic findings. Elevated NLR, PLR and SII can be considered as prognostic and risk stratifying factor of severe form of disease. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-020-05540-3. BioMed Central 2020-11-23 /pmc/articles/PMC7680983/ /pubmed/33225909 http://dx.doi.org/10.1186/s12879-020-05540-3 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Rokni, Mohsen
Ahmadikia, Kazem
Asghari, Somaye
Mashaei, Shahabodin
Hassanali, Fahimeh
Comparison of clinical, para-clinical and laboratory findings in survived and deceased patients with COVID-19: diagnostic role of inflammatory indications in determining the severity of illness
title Comparison of clinical, para-clinical and laboratory findings in survived and deceased patients with COVID-19: diagnostic role of inflammatory indications in determining the severity of illness
title_full Comparison of clinical, para-clinical and laboratory findings in survived and deceased patients with COVID-19: diagnostic role of inflammatory indications in determining the severity of illness
title_fullStr Comparison of clinical, para-clinical and laboratory findings in survived and deceased patients with COVID-19: diagnostic role of inflammatory indications in determining the severity of illness
title_full_unstemmed Comparison of clinical, para-clinical and laboratory findings in survived and deceased patients with COVID-19: diagnostic role of inflammatory indications in determining the severity of illness
title_short Comparison of clinical, para-clinical and laboratory findings in survived and deceased patients with COVID-19: diagnostic role of inflammatory indications in determining the severity of illness
title_sort comparison of clinical, para-clinical and laboratory findings in survived and deceased patients with covid-19: diagnostic role of inflammatory indications in determining the severity of illness
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680983/
https://www.ncbi.nlm.nih.gov/pubmed/33225909
http://dx.doi.org/10.1186/s12879-020-05540-3
work_keys_str_mv AT roknimohsen comparisonofclinicalparaclinicalandlaboratoryfindingsinsurvivedanddeceasedpatientswithcovid19diagnosticroleofinflammatoryindicationsindeterminingtheseverityofillness
AT ahmadikiakazem comparisonofclinicalparaclinicalandlaboratoryfindingsinsurvivedanddeceasedpatientswithcovid19diagnosticroleofinflammatoryindicationsindeterminingtheseverityofillness
AT asgharisomaye comparisonofclinicalparaclinicalandlaboratoryfindingsinsurvivedanddeceasedpatientswithcovid19diagnosticroleofinflammatoryindicationsindeterminingtheseverityofillness
AT mashaeishahabodin comparisonofclinicalparaclinicalandlaboratoryfindingsinsurvivedanddeceasedpatientswithcovid19diagnosticroleofinflammatoryindicationsindeterminingtheseverityofillness
AT hassanalifahimeh comparisonofclinicalparaclinicalandlaboratoryfindingsinsurvivedanddeceasedpatientswithcovid19diagnosticroleofinflammatoryindicationsindeterminingtheseverityofillness